Medpace Holdings, Inc. Files 8-K on Financials
Ticker: MEDP · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: MEDP
TL;DR
MEDPACE filed an 8-K today, expect financial updates soon.
AI Summary
On July 22, 2024, Medpace Holdings, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the initial filing information.
Why It Matters
This 8-K filing indicates Medpace Holdings, Inc. is providing updates on its financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Medpace Holdings, Inc. (company) — Registrant
- 0001668397-24-000140 (filing_id) — Accession Number
- July 22, 2024 (date) — Report Date
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details are not provided in the header information.
When was this 8-K report filed?
The report was filed on July 22, 2024.
What is Medpace Holdings, Inc.'s principal executive office address?
The principal executive offices are located at 5375 Medpace Way, Cincinnati, Ohio 45227.
What is Medpace Holdings, Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number for Medpace Holdings, Inc. is 32-0434904.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 553 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-07-22 16:16:05
Key Financial Figures
- $0.01 — hange on which registered Common Stock $0.01 par value MEDP NASDAQ Global Select Mar
Filing Documents
- medp-20240722.htm (8-K) — 27KB
- medp-20240722exx991.htm (EX-99.1) — 173KB
- medpace-logoxonxwhite.jpg (GRAPHIC) — 10KB
- 0001668397-24-000140.txt ( ) — 350KB
- medp-20240722.xsd (EX-101.SCH) — 2KB
- medp-20240722_lab.xml (EX-101.LAB) — 21KB
- medp-20240722_pre.xml (EX-101.PRE) — 12KB
- medp-20240722_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On July 22, 2024, Medpace Holdings, Inc. (the "Company") issued a press release announcing its financial results for the three and six months ended June 30, 2024. The full text of the press release was posted on the Company's internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated Ju ly 22 , 202 4 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MEDPACE HOLDINGS, INC. Date: July 22, 2024 By: /s/ Kevin M. Brady Kevin M. Brady, Chief Financial Officer